BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7924434)

  • 1. Cytotoxic T cells and human herpes virus infections.
    Borysiewicz LK; Sissons JG
    Curr Top Microbiol Immunol; 1994; 189():123-50. PubMed ID: 7924434
    [No Abstract]   [Full Text] [Related]  

  • 2. Immune surveillance against Epstein-Barr virus.
    Moss DJ; Burrows SR; Khanna R; Misko IS; Sculley TB
    Semin Immunol; 1992 Apr; 4(2):97-104. PubMed ID: 1377517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How viruses hide from T cells.
    McMichael A
    Trends Microbiol; 1997 Jun; 5(6):211-2; discussion 212-3. PubMed ID: 9211637
    [No Abstract]   [Full Text] [Related]  

  • 4. [Repertoire of epitopes of human immunodeficiency virus proteins and the search for vaccines and diagnostic kits].
    Kharchenko EP; Klimenko AP
    Dokl Akad Nauk SSSR; 1992; 322(1):189-92. PubMed ID: 1380907
    [No Abstract]   [Full Text] [Related]  

  • 5. Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response.
    Steven NM; Annels NE; Kumar A; Leese AM; Kurilla MG; Rickinson AB
    J Exp Med; 1997 May; 185(9):1605-17. PubMed ID: 9151898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic T lymphocytes in herpesvirus infections.
    Rouse BT; Horohov DW
    Vet Immunol Immunopathol; 1984 May; 6(1-2):35-66. PubMed ID: 6330966
    [No Abstract]   [Full Text] [Related]  

  • 7. Selection of a diverse TCR repertoire in response to an Epstein-Barr virus-encoded transactivator protein BZLF1 by CD8+ cytotoxic T lymphocytes during primary and persistent infection.
    Silins SL; Cross SM; Elliott SL; Pye SJ; Burrows JM; Moss DJ; Misko IS
    Int Immunol; 1997 Nov; 9(11):1745-55. PubMed ID: 9418135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marijuana and host resistance to herpesvirus infection.
    Cabral GA; Pettit DA; Fischer-Stenger K
    Adv Exp Med Biol; 1993; 335():95-106. PubMed ID: 7694448
    [No Abstract]   [Full Text] [Related]  

  • 9. Induction of protective immunity using minigenes.
    Whitton JL
    Ann N Y Acad Sci; 1994 Aug; 730():107-17. PubMed ID: 7521600
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of bovine mammillitis virus towards preparation of an alternative vaccine against herpes simplex virus infections of human subjects.
    Skinner GR; Buchan A; Durham J; Cowan M; Davies J; Brookes K; Castrucci G
    Vaccine; 1987 Mar; 5(1):55-9. PubMed ID: 3033927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetically engineered herpes simplex virus vaccines.
    Watson RJ; Enquist LW
    Prog Med Virol; 1985; 31():84-108. PubMed ID: 2982176
    [No Abstract]   [Full Text] [Related]  

  • 12. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. III. Analysis of viral glycoproteins recognized by CTL clones by using recombinant herpes simplex viruses.
    Yasukawa M; Zarling JM
    J Immunol; 1985 Apr; 134(4):2679-82. PubMed ID: 2579149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The T-lymphocyte response to varicella-zoster viral proteins.
    Arvin AM; Koropchak CM; Sharp M; Bergen R; Diaz PS
    Adv Exp Med Biol; 1990; 278():71-81. PubMed ID: 1963047
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunological studies in herpes simplex].
    Rust S
    Arch Dermatol Forsch; 1972; 244():320-2. PubMed ID: 4346244
    [No Abstract]   [Full Text] [Related]  

  • 15. Bovine Herpesvirus-4-Based Vector Delivering Peste des Petits Ruminants Virus Hemagglutinin ORF Induces both Neutralizing Antibodies and Cytotoxic T Cell Responses.
    Macchi F; Rojas JM; Verna AE; Sevilla N; Franceschi V; Tebaldi G; Cavirani S; Martín V; Donofrio G
    Front Immunol; 2018; 9():421. PubMed ID: 29556236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection.
    Rickinson AB; Moss DJ
    Annu Rev Immunol; 1997; 15():405-31. PubMed ID: 9143694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The BZLF1 homolog of an Epstein-Barr-related gamma-herpesvirus is a frequent target of the CTL response in persistently infected rhesus macaques.
    Fogg MH; Garry D; Awad A; Wang F; Kaur A
    J Immunol; 2006 Mar; 176(6):3391-401. PubMed ID: 16517707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of B virus and herpes simplex virus antibodies in human sera.
    Cabasso VJ; Chappell WA; Avampato JE; Bittle JL
    J Lab Clin Med; 1967 Jul; 70(1):170-8. PubMed ID: 4290842
    [No Abstract]   [Full Text] [Related]  

  • 19. Expression of herpes simplex virus ICP47 and human cytomegalovirus US11 prevents recognition of transgene products by CD8(+) cytotoxic T lymphocytes.
    Berger C; Xuereb S; Johnson DC; Watanabe KS; Kiem HP; Greenberg PD; Riddell SR
    J Virol; 2000 May; 74(10):4465-73. PubMed ID: 10775582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen.
    Burrows SR; Silins SL; Moss DJ; Khanna R; Misko IS; Argaet VP
    J Exp Med; 1995 Dec; 182(6):1703-15. PubMed ID: 7500015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.